James Beedie, PHD in Anchorage, AK - Counselor

James Beedie, PHD is a Counselor - Mental Health based in Anchorage, Alaska. James Beedie is licensed to practice in Alaska (license number 110271) and his current practice location is 8717 Dimond D Cir, Anchorage, Alaska. He can be reached at his office (for appointments etc.) via phone at (907) 771-0536.

NPI number for James Beedie is 1659808574 and his current mailing address is 16200 Sandpiper Dr, Anchorage, Alaska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1659808574.

Contact Information

	James Beedie, PHD
	8717 Dimond D Cir, Anchorage, AK 99515-1931
	(907) 771-0536
	(907) 771-0537

Healthcare Provider's Profile

Full Name	James Beedie
Gender	Male
Speciality	Counselor - Mental Health
Location	8717 Dimond D Cir, Anchorage, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1659808574
Provider Enumeration Date: 05/23/2017
Last Update Date: 05/23/2017

Medical Identifiers

Medical identifiers for James Beedie such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659808574	NPI	-	NPPES
1021093	Medicaid	AK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TB0200X	Psychologist - Cognitive & Behavioral	110271 (Alaska)	Secondary
101YM0800X	Counselor - Mental Health	110271 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James Beedie is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
James Beedie, PHD 16200 Sandpiper Dr, Anchorage, AK 99516-5052 Ph: () -	James Beedie, PHD 8717 Dimond D Cir, Anchorage, AK 99515-1931 Ph: (907) 771-0536

News Archive

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Panic disorder is a syndrome characterized by spontaneous and recurrent episodes of incapacitating anxiety. It typically emerges during adolescence or early adulthood and can take an exhausting emotional and physical toll on the body.

Pro-inflammatory diet may be associated with increased risk of testosterone deficiency in men

Consuming a diet high in pro-inflammatory foods - including foods that contain refined carbohydrates and sugar as well as polyunsaturated fats - may be associated with increased odds of developing testosterone deficiency among men, suggests a study in The Journal of Urology, Official Journal of the American Urological Association.

On back roads of Appalachia's coal country, mental health services are as rare as jobs

Every other month, Tanya Nelson travels 32 miles from the heart of Appalachia's coal country for an appointment with the nearest psychiatrist for therapy and to renew prescriptions. But the commute, which should take less than an hour through the winding mountain roads of southern West Virginia, consumes her entire day.

New ‘nanotech' weapon against drug-resistant superbugs

Scientists at the Institute of Bioengineering and Nanotechnology (IBN) and IBM Research – Almaden have developed the first biodegradable polymer nanoparticles to combat drug-resistant superbugs, such as Methicillin-Resistant Staphylococcus aureus (MRSA). These nanoparticles can selectively kill the bacteria without destroying healthy red blood cells, and being biodegradable, have great potential to treat infectious diseases in the body. This was reported today in the leading scientific journal, Nature Chemistry [(2011) DOI: 10.1038/nchem.1012].

James Beedie, PHD - in Anchorage, AK